VACIS

medical devices

About

VACIS has developed a platform technology to provide autologous soft tissue solutions to patients. VACIS is trading under the tradename Curotis - www.curotis.nl / https://www.linkedin.com/company/curotis/ The goal of VACIS' products is to improve patients lives by offering autologous tissue alternatives to currently available artificial solutions. The clinical applications range from vascular access to urology. Interest has also been shown in the field of reconstructive surgery and neurology. After extensive preclinical research, with its results published in multiple scientific journals VACIS has successfully concluded their clinical study and is on the pathway to CE certification within the EU. VACIS is providing solutions of the highest quality which is continously monitored through our ISO13485 certification since 2020.

Technologies

Gmail Google Apps Bootstrap Framework WordPress.org Apache Google Font API Mobile Friendly Remote

Keywords

biotechnology hemodialysis access urology cardiovascular regenerative medicine medical equipment manufacturing autologous blood vessels vascular surgery tissue engineering biocompatibility synthetic rod blood circulation in situ formation vascular grafts peripheral arterial occlusive disease vessel maturation fibrocollagenous tissue sustained patency therapeutic options medical devices synthetic grafts foreign materials complications management vascular access biotechnology innovations cellular integration vascular graft failure patient-specific solutions surgical applications biomedical engineering

Location

Gaetano Martinolaan, Maastricht, Limburg, Netherlands, 6229

Related Companies

Companies in the same industry